#21toWatch 2026 winners revealed: deeptech founders tackling society’s toughest health and climate challenges
The #21toWatch Top21.2026 winners have been announced at an awards ceremony at The Glasshouse innovation hub in Cambridge.
New AI in genomics fellowship with the Sanger Institute and Google DeepMind
A new Google DeepMind Academic Fellowship will be hosted at the Wellcome Sanger Institute, exploring the application of artificial intelligence (AI) in genomics through a first-of-its-kind opportunity.
Mursla Bio accelerates US commercial deployment of EvoLiver through ABHI Programme
Provides structured US market access for EvoLiver FDA-designated liver cancer surveillance test across health systems, payors and clinical stakeholders
How can you maximise ROI in product development?
For many first-time founders, developing a physical product feels like spinning multiple plates at once.
🔬 Antibody Drugs · Integrated NAMs Nonclinical Strategy
As global regulators, including the FDA, move toward phasing out animal testing for monoclonal antibodies, New Approach Methodologies (NAMs) such as AI models, organoids, and organ-on-chip systems are becoming central to nonclinical development.
OBN Invites Life Science leaders to celebrate 20 years of BioTrinity
Featuring keynotes from: Steve Bates, Executive Chair at the Office for Life Sciences, Lawrence Tallon, CEO at the MHRA & Maria Koufali, Life Sciences Industry Director at the NIHR, click here
What’s your browser really doing?
Your team’s web browser seems harmless. Just tabs, websites, and the odd Google search.
But a new wave of AI-powered browsers is quietly changing what a browser actually does. And that raise some important questions.
Wisdom Bioscience establishes Scientific Advisory Board to advance oral cancer diagnostics and screening
• Drs Giulia Kennedy, Arnold Levine, John Sninsky, Martin Goldberg and Prof Tin Tin Su join SAB• Follows close of initial funding round with investment from Stephen Quake and Jay Flatley
Babraham Research Campus Ltd appoints Dr Rich Ferrie as Chief Executive Officer
Babraham Research Campus Ltd (BRCL), which is responsible for the development and management of Babraham Research Campus, is delighted to announce the appointment of Dr Rich Ferrie to the role of Chief Executive Officer.
Genomic study helps detect baby’s rare growth condition
Doctors at Cambridge University Hospitals are “thrilled” by a baby’s positive response to treatment after her rare genetic condition was diagnosed following results from a national screening study.
Isopod Rapid Cleanrooms: the versatile modular pod system that adapts to suit any host room configuration
Guardtech’s rapid pod solution can be relocated and expanded to match a business’ growth whilst preserving host room integrity with an unassailable level of flexibility
SPT Labtech to collaborate with Illumina to develop automated platform supporting genomics in decentralized healthcare settings
SPT Labtech to develop an automated sample preparation platform for Illumina to further optimize the efficiency and benefits of genomic workflows in decentralized healthcare settingsBuilds on success of existing partnership including development of automated library pre
ELRIG appoints Dr Kelly Gray and Dr Elaine Duncan to its Board
*Strengthens leadership team to support next phase of growth as organisation evolves to meet needs of global drug discovery community *Drs Gray and Duncan to lead scientific programmes and early career initiatives, respectively
SolasCure completes phase II clinical trial, demonstrating accelerated healing with Aurase Wound Gel
Aurase Wound Gel shows 22x faster debridement and 7x faster healing compared to standard of care in sloughy venous leg ulcers, supporting advancement to the next phase of developmentData confirms dual mechanism of action, including activation of tissue repair pathways i
Centauri Therapeutics extends Series A to £30M with £6M investment from AMR Action Fund to support progression of lead clinical candidate
Clinical candidate in ABX-01 programme, CTX-187, currently in development ahead of first in-human clinical trials to target Gram-negative bacterial infectionsInvestment from the world’s largest venture capital fund focused exclusively on antimicrobial therapeutics and d
Syndex Bio unveils mcPCR Technology at AGBT 2026 following $15.5M seed financing
• mcPCR enables precise copying of DNA methylation during DNA amplification, overcoming a fundamental limitation of PCR, and unlocks new opportunities for sensitive detection of cancer, chronic disease, and in basic research
This PowerPoint feature has disappeared
If your team creates presentations often, you may have noticed a recent change in Microsoft PowerPoint.
Microsoft has quietly removed a feature that helped you keep your branding and formatting consistent.
Here’s what this means for you:
Announcing the inaugural Imposter Phenomenon Awareness Day
Dr Kate Atkin and Dr Terri Simpkin are launching the inaugural International Imposter Phenomenon Awareness Day on Friday 27th February. Why phenomenon and not Syndrome? Because words matter and they can give you power to change or take it away.
Loughborough University and Science in Sport (SiS) extend partnership in elite sport and performance nutrition
Loughborough and Blackburn, UK, 23 February 2026: Loughborough University and Science in Sport (SiS) announces a renewed three-year partnership, strengthening the organisations’ long-standing collaboration across elite sport and performance nutrition.
Before Partnership: Why Qualification Determines Whether Innovation Can Scale
Why early governance readiness determines whether proof can become practice
At last: Sync passkeys across your devices
Be honest, when was the last time you forgot a password and ended up in that endless loop of “reset your password” emails?
It’s one of the biggest frustrations of modern working life.
CCDC announces AI Technology partnership with Sapio Sciences
New Collaboration Brings GOLD Protein–Ligand Docking Capabilities to Sapio ELaiN — the World’s First 3rd‑Generation AI Laboratory Notebook
The Cambridge Crystallographic Data Centre (CCDC), a global leader
Axol Bioscience acquires ophthalmology business from Newcells Biotech
· Acquisition expands Axol’s portfolio of iPSC-derived retinal organoid and retinal pigment epithelium (RPE) models
Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins
Partnership will deliver AI-guided end-to-end workflow to access challenging membrane protein targetsTo de-risk and shorten path to critical structural and biophysical insights that inform structure-based drug designCambridge, UK, Boston MA, USA and Vi
KluraLabs secures £8 Million to scale packaging innovation and reduce food waste globally
KluraLabs, The EpiCentre-based materials science company transforming food packaging in Haverhill, has successfully raised £8 million in funding to accelerate the rollout of its pioneering technology across global retail supply chains.